SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pia Frisk, Sofia K Sporrong, Gunnar Ljunggren, Björn Wettermark, Mia von Euler, Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden, European Journal of Clinical Pharmacology, 2016,

    CrossRef

  2. 2
    Werner J. Becker, Acute Migraine Treatment in Adults, Headache: The Journal of Head and Face Pain, 2015, 55, 6
  3. 3
    Stephen H. Landy, Ira M. Turner, M. Chris Runken, Mechele Lee, Ellen Sulcs, Christopher F. Bell, A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy, Headache: The Journal of Head and Face Pain, 2013, 53, 7
  4. 4
    Christian Lampl, Michael Voelker, Timothy J. Steiner, Aspirin is First-Line Treatment for Migraine and Episodic Tension-Type Headache Regardless of Headache Intensity, Headache: The Journal of Head and Face Pain, 2012, 52, 1
  5. 5
    American Pharmacists Association, Loosening the grip of migraine attacks, Pharmacy Today, 2012, 18, 1, 61

    CrossRef

  6. 6
    Peer Tfelt-Hansen, Jes Olesen, Taking the Negative View of Current Migraine Treatments, CNS Drugs, 2012, 26, 5, 375

    CrossRef

  7. You have free access to this content7
    H. Göbel, A. Heinze, The Migraine Intervention Score – a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study, International Journal of Clinical Practice, 2011, 65, 8
  8. 8
    Anders Hougaard, Peer Tfelt-Hansen, Are the current IHS guidelines for migraine drug trials being followed?, The Journal of Headache and Pain, 2010, 11, 6, 457

    CrossRef

  9. 9
    Frank Berenson, Elza Vasconcellos, Ann Pakalnis, Lian Mao, David M. Biondi, Robert B. Armstrong, Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents, Headache: The Journal of Head and Face Pain, 2010, 50, 5
  10. 10
    Starr H. Pearlman, David W. Dodick, Headache, 2010,

    CrossRef

  11. 11
    Henry Hu, Tobias Kurth, Roger Cady, Nancy Santanello, Marcelo E. Bigal, Acute Migraine Treatment With Rizatriptan in Real World Settings – Focusing on Treatment Strategy, Effectiveness, and Behavior, Headache: The Journal of Head and Face Pain, 2009, 49,
  12. 12
    Roger K. Cady, Frederick G. Freitag, Ninan T. Mathew, Arthur H. Elkind, Lian Mao, Alan C. Fisher, David M. Biondi, Gary Finlayson, Steven J. Greenberg, Joseph F. Hulihan, Allodynia-Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention, Headache: The Journal of Head and Face Pain, 2009, 49, 3
  13. 13
    D Valade, Early treatment of acute migraine: new evidence of benefits, Cephalalgia, 2009, 29,
  14. 14
    Ninan T. Mathew, Stephen Landy, Stuart Stark, Gretchen E. Tietjen, Frederick J. Derosier, Jonathan White, Shelly E. Lener, Deo Bukenya, Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life, Headache: The Journal of Head and Face Pain, 2009, 49, 7
  15. 15
    Mike Namaka, Christine Leong, Amy Grossberndt, Meghann Klowak, Chris Louizos, Jenny Drummond, Ewa Leligdowicz, Melanie Lichkowski, Maria Melanson, Managing migraines: Options for acute abortive treatment, Canadian Pharmacists Journal, 2009, 142, 4, 190

    CrossRef

  16. 16
    Roger K. Cady, James Banks, Beverly A. Jones, John Campbell, Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination, Current Medical Research and Opinion, 2009, 25, 11, 2711

    CrossRef

  17. 17
    DW Dodick, Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine), Cephalalgia, 2009, 29,
  18. 18
    Roger K. Cady, Vincent T. Martin, Gilles Géraud, Anthony Rodgers, Ying Zhang, Andrew P. Ho, Carolyn M. Hustad, Tony W. Ho, Kathryn M. Connor, Karen E. Ramsey, Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education on Treatment Response, Headache: The Journal of Head and Face Pain, 2009, 49, 5
  19. 19
    Stephen D. Silberstein, Todd Berner, John Tobin, Qinfang Xiang, John C. Campbell, Scheduled Short-Term Prevention With Frovatriptan for Migraine Occurring Exclusively in Association With Menstruation, Headache: The Journal of Head and Face Pain, 2009, 49, 9
  20. 20
    Richard J. Hargreaves, Chris R. Lines, Alan M. Rapoport, Tony W. Ho, Fred D. Sheftell, Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions, Headache: The Journal of Head and Face Pain, 2009, 49,
  21. You have free access to this content21
    DS Ng-Mak, L Ma, XH Hu, Y-T Chen, Treat-early and treat-mild: role of fast vs. slow escalation of headaches, Cephalalgia, 2009, 29, 4
  22. 22
    Lisa K Mannix, A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future, Expert Opinion on Pharmacotherapy, 2008, 9, 6, 1001

    CrossRef

  23. 23
    X. Henry Hu, Daisy Ng-Mak, Roger Cady, Does Early Migraine Treatment Shorten Time to Headache Peak and Reduce Its Severity?, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  24. You have free access to this content24
    A Gendolla, Early treatment in migraine: how strong is the current evidence?, Cephalalgia, 2008, 28,
  25. 25
    E. Cittadini, P.J. Goadsby, Intranasal Zolmitriptan Is Effective and Well Tolerated in Acute Cluster Headache: A Randomized Placebo-Controlled Double-Blind Crossover Study, Progress in Neurotherapeutics and Neuropsychopharmacology, 2008, 3, 01

    CrossRef

  26. 26
    P Tfelt-Hansen, Maximum effect of triptans in migraine? A comment, Cephalalgia, 2008, 28, 7
  27. 27
    Peer Tfelt-Hansen, Kim Brøsen, Pharmacogenomics and migraine: possible implications, The Journal of Headache and Pain, 2008, 9, 1, 13

    CrossRef

  28. You have free access to this content28
    P. J. Goadsby, H. Massiou, J. Pascual, H.-C. Diener, C. G. H. Dahlöf, V. Mateos, A. J. Dowson, I. Raets, L. Cunha, M. Färkkilä, G. C. Manzoni, Almotriptan and zolmitriptan in the acute treatment of migraine, Acta Neurologica Scandinavica, 2007, 115, 1
  29. You have free access to this content29
    Daisy S. Ng-Mak, Roger Cady, Ya-Ting Chen, Larry Ma, Christopher F. Bell, X. Henry Hu, Can Migraineurs Accurately Identify Their Headaches as “Migraine” at Attack Onset?, Headache: The Journal of Head and Face Pain, 2007, 47, 5
  30. 30
    Ninan T. Mathew, Gary Finlayson, Timothy R. Smith, Roger K. Cady, James Adelman, Lian Mao, Pamela Wright, Steven J. Greenberg, Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT® Early Migraine Intervention Study), Headache: The Journal of Head and Face Pain, 2007, 47, 2
  31. 31
    Frederick G. Freitag, Gary Finlayson, Alan M. Rapoport, Arthur H. Elkind, Merle L. Diamond, Jeffrey R. Unger, Alan C. Fisher, Robert B. Armstrong, Joseph F. Hulihan, Steven J. Greenberg, Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT® 12.5 mg Time Versus Intensity Migraine Study (AIMS), Headache: The Journal of Head and Face Pain, 2007, 47, 4
  32. 32
    Peer Tfelt-Hansen, Timothy J Steiner, Over-the-Counter Triptans for Migraine, CNS Drugs, 2007, 21, 11, 877

    CrossRef

  33. 33
    Robert Janknegt, Triptans in the treatment of migraine: drug selection by means of the SOJA method, Expert Opinion on Pharmacotherapy, 2007, 8, sup1, S15

    CrossRef

  34. 34
    William Pryse-Phillips, Michel Aubé, Peter Bailey, Werner J. Becker, Andre Bellavance, Marek Gawel, Rose Giammarco, Gordon Mackie, R. Allan Purdy, Gordon Robinson, Gary Shapero, Keith Wilson, A Clinical Study of Migraine Evolution, Headache: The Journal of Head and Face Pain, 2006, 46, 10
  35. 35
    P Sarchielli, LA Pini, G Zanchin, A Alberti, F Maggioni, C Rossi, A Floridi, P Calabresi, Clinical–biochemical correlates of migraine attacks in rizatriptan responders and non-responders, Cephalalgia, 2006, 26, 3
  36. 36
    Carl Dahlöf, Cutaneous allodynia and migraine: Another view, Current Pain and Headache Reports, 2006, 10, 3, 231

    CrossRef

  37. 37
    Domenico D’Amico, Franca Moschiano, Gennaro Bussone, Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?, Expert Review of Neurotherapeutics, 2006, 6, 7, 1087

    CrossRef

  38. 38
    Roger Cady, Curtis Schreiber, Frovatriptan: clinical review and future directions, Future Neurology, 2006, 1, 1, 13

    CrossRef

  39. 39
    Robert Kaniecki, Intercepting migraine: Results of early therapy with nonspecific and migraine-specific agents, Current Treatment Options in Neurology, 2006, 8, 1, 3

    CrossRef

  40. 40
    David M. Biondi, Is migraine a neuropathic pain syndrome?, Current Pain and Headache Reports, 2006, 10, 3, 167

    CrossRef

  41. 41
    Susan E. Jelinski, Werner J. Becker, Suzanne N. Christie, Faiz F. Ahmad, William Pryse-Phillips, Scott D. Simpson, Pain Free Efficacy of Sumatriptan in the Early Treatment of Migraine, The Canadian Journal of Neurological Sciences, 2006, 33, 01, 73

    CrossRef

  42. 42
    A. J. DOWSON, N. T. MATHEW, J. PASCUAL, Review of clinical trials using early acute intervention with oral triptans for migraine management, International Journal of Clinical Practice, 2006, 60, 6
  43. 43
    Miguel JA Láinez, Rizatriptan in the treatment of migraine, Neuropsychiatric Disease and Treatment, 2006, 2, 3, 247

    CrossRef

  44. 44
    AV Krymchantowski, PFM Filho, ME Bigal, Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study, Cephalalgia, 2006, 26, 7
  45. 45
    Christian Lucas, Strategies to Improve Migraine Treatment Results, Drugs, 2006, 66, Suppl 3, 9???16

    CrossRef

  46. 46
    M Linde, A Mellberg, C Dahlöf, Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack, Cephalalgia, 2006, 26, 2
  47. 47
    Natalie J. Wiendels, Michel D. Ferrari, Treating Migraine Attacks ASAP: Concept and Methodological Issues, Progress in Neurotherapeutics and Neuropsychopharmacology, 2006, 1, 01, 53

    CrossRef

  48. 48
    Jerome Goldstein, Stephen D. Silberstein, Joel R. Saper, Arthur H. Elkind, Timothy R. Smith, R. Michael Gallagher, Jean-Pierre Battikha, Howard Hoffman, Jeffrey Baggish, Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial, Headache: The Journal of Head and Face Pain, 2005, 45, 8
  49. 49
    Hans-Christoph Diener, Headache, Current Opinion in Neurology, 2005, 18, 3, 279

    CrossRef

  50. 50
    Stefan Evers, Achim Frese, Recent advances in the treatment of headaches, Current Opinion in Anaesthesiology, 2005, 18, 5, 563

    CrossRef

  51. 51
    Michel D. Ferrari, Should We Advise Patients to Treat Migraine Attacks Early: Methodologic Issues, European Neurology, 2005, 53, 1, 17

    CrossRef

  52. 52
    Kathleen A. Foley, Roger Cady, Vincent Martin, James Adelman, Merle Diamond, Christopher F. Bell, Jeffrey M. Dayno, X. Henry Hu, Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine, Headache: The Journal of Head and Face Pain, 2005, 45, 5
  53. 53
    Peer Tfelt-Hansen, Headache,